ArticleRheumatology international2019

Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage.

Onay Gercik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.